SEARCH RESULTS FOR: （薇信11008748）推特微密圈Onlyfans推荐大啵G奶御姐喵了个眯儿道具自慰炮机爆操爽晕了.dxl(39486 results)
Only the first 10,000 results were returned. Filter these results or refine your query. Some pre-built queries with more than 10,000 results are available for download.
T-MAT G/RA 50SH 12.7x30.5cm film
CARESTREAM HEALTH, INC.
T-MAT G/RA
In Commercial Distribution
- 60889971987624 ()
- 40889971987620 ()
- 00889971987622 ()
1987627
- Dental x-ray film, screen
T-MAT G/RA 50SH 15x30cm film
CARESTREAM HEALTH, INC.
T-MAT G/RA
In Commercial Distribution
- 60889971869081 ()
- 40889971869087 ()
- 00889971869089 ()
1869080
- Dental x-ray film, screen
CERAMENT G is an implantable bone void filler (device/ drug combination product) indicated for use as an adjunct to systemic antibiotic therapy and surgical debridement (standard treatment approach to a bone infection) where there is a need for supplemental bone graft.
CERAMENT G combines gentamicin sulfate with a bone void filler, consisting of hydroxyapatite and calcium sulfate.
By eluting gentamicin, CERAMENT G can reduce the recurrence of chronic osteomyelitis from gentamicin-sensitive microorganisms in order to protect bone healing CERAMENT G can also reduce the likelihood of infection subsequent to an open fracture.
By combining calcium sulfate and hydroxyapatite, a balance is achieved between implant resorption rate and bone remodeling rate. Calcium sulfate acts as a resorbable carrier for hydroxyapatite. Hydroxyapatite has a slow resorption rate and high osteoconductivity providing a scaffold for new bone generation.
The use of CERAMENT G eliminates the need to harvest autologous bone, thereby avoiding donor site morbidity (e.g., pain, infection, etc.) in patients with a diagnosed infection.
CERAMENT G may be implanted by an injectable system. In bone infection, CERAMENT G can also be inserted as pre-set beads.
Bone Support AB
A0535-06
In Commercial Distribution
- 07350055430530 ()
- Total Volume: 5 Milliliter
- Bone matrix implant, synthetic, antimicrobial
CERAMENT G is an implantable bone void filler (device/ drug combination product) indicated for use as an adjunct to systemic antibiotic therapy and surgical debridement (standard treatment approach to a bone infection) where there is a need for supplemental bone graft.
CERAMENT G combines gentamicin sulfate with a bone void filler, consisting of hydroxyapatite and calcium sulfate.
By eluting gentamicin, CERAMENT G can reduce the recurrence of chronic osteomyelitis from gentamicin-sensitive microorganisms in order to protect bone healing CERAMENT G can also reduce the likelihood of infection subsequent to an open fracture.
By combining calcium sulfate and hydroxyapatite, a balance is achieved between implant resorption rate and bone remodeling rate. Calcium sulfate acts as a resorbable carrier for hydroxyapatite. Hydroxyapatite has a slow resorption rate and high osteoconductivity providing a scaffold for new bone generation.
The use of CERAMENT G eliminates the need to harvest autologous bone, thereby avoiding donor site morbidity (e.g., pain, infection, etc.) in patients with a diagnosed infection.
CERAMENT G may be implanted by an injectable system. In bone infection, CERAMENT G can also be inserted as pre-set beads.
Bone Support AB
A0535-05
In Commercial Distribution
- 07350055430523 ()
- Total Volume: 10 Milliliter
- Bone matrix implant, synthetic, antimicrobial
CERAMENT G is an implantable bone void filler (device/ drug combination product) indicated for use as an adjunct to systemic antibiotic therapy and surgical debridement (standard treatment approach to a bone infection) where there is a need for supplemental bone graft.
CERAMENT G combines gentamicin sulfate with a bone void filler, consisting of hydroxyapatite and calcium sulfate.
By eluting gentamicin, CERAMENT G can reduce the recurrence of chronic osteomyelitis from gentamicin-sensitive microorganisms in order to protect bone healing.
By combining calcium sulfate and hydroxyapatite, a balance is achieved between implant resorption rate and bone remodeling rate. Calcium sulfate acts as a resorbable carrier for hydroxyapatite. Hydroxyapatite has a slow resorption rate and high osteoconductivity providing a scaffold for new bone generation.
The use of CERAMENT G eliminates the need to harvest autologous bone, thereby avoiding donor site morbidity (e.g., pain, infection, etc.) in patients with a diagnosed infection.
CERAMENT G may be implanted by an injectable system or inserted as pre-set beads.
Bone Support AB
A0450-11
In Commercial Distribution
- 07350055430394 ()
- Total Volume: 5 Milliliter
- Bone matrix implant, synthetic, antimicrobial
CERAMENT G is an implantable bone void filler (device/ drug combination product) indicated for use as an adjunct to systemic antibiotic therapy and surgical debridement (standard treatment approach to a bone infection) where there is a need for supplemental bone graft.
CERAMENT G combines gentamicin sulfate with a bone void filler, consisting of hydroxyapatite and calcium sulfate.
By eluting gentamicin, CERAMENT G can reduce the recurrence of chronic osteomyelitis from gentamicin-sensitive microorganisms in order to protect bone healing.
By combining calcium sulfate and hydroxyapatite, a balance is achieved between implant resorption rate and bone remodeling rate. Calcium sulfate acts as a resorbable carrier for hydroxyapatite. Hydroxyapatite has a slow resorption rate and high osteoconductivity providing a scaffold for new bone generation.
The use of CERAMENT G eliminates the need to harvest autologous bone, thereby avoiding donor site morbidity (e.g., pain, infection, etc.) in patients with a diagnosed infection.
CERAMENT G may be implanted by an injectable system or inserted as pre-set beads.
Bone Support AB
A0450-10
In Commercial Distribution
- 07350055430387 ()
- Total Volume: 10 Milliliter
- Bone matrix implant, synthetic, antimicrobial
This nickel alloy can be veneered using most high melt ceramics.
Schütz Dental GmbH
622323
In Commercial Distribution
- ESDG6223231 ()
- Dental casting non-noble alloy
This nickel alloy can be veneered using most high melt ceramics.
Schütz Dental GmbH
622322
In Commercial Distribution
- ESDG6223221 ()
- Dental casting non-noble alloy
No Description
Lonza Walkersville, Inc.
15-1004J
In Commercial Distribution
- 00840075403159 ()
15-1004J
- Ex vivo cell culture medium
No Description
Roche Molecular Systems, Inc.
07402678190
In Commercial Distribution
- 00875197005646 ()
07402678190
- Beta-haemolytic Group A Streptococcus nucleic acid IVD, control